KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Revenue (2017 - 2025)

Twist Bioscience (TWST) has disclosed Revenue for 9 consecutive years, with $103.7 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 16.89% to $103.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $391.6 million through Dec 2025, up 18.59% year-over-year, with the annual reading at $376.6 million for FY2025, 20.32% up from the prior year.
  • Revenue for Q4 2025 was $103.7 million at Twist Bioscience, up from $99.0 million in the prior quarter.
  • The five-year high for Revenue was $103.7 million in Q4 2025, with the low at $31.2 million in Q1 2021.
  • Average Revenue over 5 years is $67.3 million, with a median of $65.3 million recorded in 2023.
  • The sharpest move saw Revenue surged 65.12% in 2021, then rose 13.59% in 2023.
  • Over 5 years, Revenue stood at $42.0 million in 2021, then rose by 29.09% to $54.2 million in 2022, then skyrocketed by 31.81% to $71.5 million in 2023, then increased by 24.08% to $88.7 million in 2024, then grew by 16.89% to $103.7 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $103.7 million, $99.0 million, and $96.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.